Description Indications It is indicated in the treatment of type 2 diabetes mellitus to improve glycemic control in adults as monotherapy or add-0n combination therapy It is indicated in patients with type 2 diabetes mellitus and established cardiovascular disease to reduce the risk of cardiovascular death. Dosage and Administration For full dosage details, see the enclosed leaflet. Administer with or without food, once daily in the morning. Contraindications Hypersensitivity to empagliflozin, linagliptin, or any component of the formulation. Refer to manufacturer labeling for further details. Common side-effects UTI, Hypoglycemia, URTI, Nasopharyngitis Reminder A doctor’s prescription is required to purchase this product. To process your order faster and to avoid cancellation of your order, upload it. During delivery, our delivery team will validate your original prescription, keep it ready. Please keep your original SC/PWD ID & booklet ready for validation if you used it during purchase.
